Recent Posts

RT @ThomasCiullaMD: Recently published, “Suprachoroidal Drug Delivery for Clinic…

RT @ThomasCiullaMD: Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Principles, Clinical Data in Uveitis, and Fu… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: Progress in the pharmacotherapy of uveitis:…

RT @ThomasCiullaMD: Just published: Progress in the pharmacotherapy of uveitis: the art of personalized care https://t.co/4gQ6cbQogQ Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinaToday: You are invited to attend a CME Symposium in Chicago in-person …


RT @RetinaToday: You are invited to attend a CME Symposium in Chicago in-person or virtual during the #AAO2022 Annual Meeting: Into the #S…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ModernRetina: The Phase 2 Altitude study evaluates the efficacy, safety, and…

RT @ModernRetina: The Phase 2 Altitude study evaluates the efficacy, safety, and tolerability of suprachoroidal delivery of RGX-314 in pati… Source by Thomas Ciulla, MD, MBA Return to main website.

Just published, “Suprachoroidal delivery enables targeting, localization and dur…

Just published, “Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions” in the Journal of Controlled Release, a high-impact leading journal on #drugdelivery systems & formulations! #suprachoroidal #retina https://t.co/25dGszj795 Source by Thomas Ciulla, MD, MBA Return to main website.

Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Princ…


Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Principles, Clinical Data in Uveitis, and Future Directions”
This paper reviews #suprachoroidal space anatomy, biomechanics, microinjector, #Xipere, #genetherapy & other trials.
https://t.co/OXcGgMU7Fv


Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Progress in the pharmacotherapy of uveitis: the art of personal…

Just published: Progress in the pharmacotherapy of uveitis: the art of personalized care https://t.co/4gQ6cbQogQ Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Excited to present on #suprachoroidal drug delivery at @Oph…

RT @ThomasCiullaMD: Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After FDA approval of #Xipere, SC delivery be… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Now in print, in this month’s British Journal of Ophthalmolo…


RT @ThomasCiullaMD: Now in print, in this month’s British Journal of Ophthalmology: Extension study of the safety and efficacy of CLS-TA fo…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Dr Steven Yeh on Patients Treated With Xipere and Its Use Ov…

RT @ThomasCiullaMD: Dr Steven Yeh on Patients Treated With Xipere and Its Use Over the Long Term https://t.co/nWhm7CUCJP via @AJMC_Journal Source by Thomas Ciulla, MD, MBA Return to main website.